DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment.
For more information about DaVita, its kidney education and its
community programs, please visit http://www.davita.com.
a. Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K,
Miskulin D, Meyer KDB, Bedrick EJ, Johnson HK, Zager PG. Which Targets
in Clinical Practice Guidelines Are Associated with Improved Survival
in a Large Dialysis Organization?, 1998 to 2004. J Am Soc Nephrol 18:
2377-2384, 2007. doi: 10.1681/ASN.2006111250.
b. Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK.
Improvements in dialysis patient mortality are associated with
improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J
Kidney Dis 2005; 45(1):127-135.
c. Duong, Uyen, Kalantar-Zadeh K, Kovesdy,C, Mehrotra, R. Mortality Trend
of Hemodialysis Chains in the USA: 1996-2004. National Kidney
Foundation Spring Clinical Meeting 2008.
|SOURCE DaVita Inc.|
Copyright©2008 PR Newswire.
All rights reserved